Skip to main content

Blood Sugar

Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
People with type 2 diabetes are far more willing than their doctors perceive to take action to achieve A1c goals
Data from Bluetooth-enabled meter can now be shared with other health tracking apps.
Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop?
Results from the type 2 diabetes group in Dexcom’s DIaMonD trial show A1c and time-in-range benefits
Amalgam Rx receives FDA clearance for basal insulin dosing app, iSage Rx; available with a prescription to adjust Lantus, Levemir, Toujeo, Tresiba, and Basaglar
Research reveals improved A1c and weight loss benefits for people with type 1 diabetes on sotagliflozin, but a slightly increased risk of DKA
Faster version of Novo Nordisk’s NovoLog approved in the US for type 1 and type 2 diabetes, launch expected as early as end of 2017
Ease, comfort, and actionable patterns, but some challenges with insurance coverage
The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr
Learn practical tips on taking care of your feet and how to easily make them a part of daily diabetes management
Lilly’s Humalog Junior KwikPen offers 0.5 unit dose increments in prefilled, disposable device – a win for highly insulin sensitive users
Why a good night of sleep transforms Adam Brown's diabetes the next day
Training to be tested in a small group before the full launch starts in June
Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...
How I avoid highs, prevent lows, and stop blood sugar frustration during exercise
How do I talk to family and friends about diabetes? Is this MY burden to bear? Are loved ones a “diabetes bright spot” or “diabetes police”?
A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...
The diaTribe Foundation convenes key diabetes experts to discuss glycemic outcomes beyond A1C on July 21, 2017, in Bethesda, MD
How to overcome the most frustrating diabetes landmine

Pages